INSULET CORPORATION (PODD) Operating Margin
- Operating margin · 12 months: Value 16.89%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 16.89% | Operating income / revenue. Period ending 2026-06-30. $515.70M ÷ $3.05B × 100 ≈ 16.89% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 515.70M USD | Operating Income (Loss) |
| Revenue | 3.05B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 883.20M USD | Cost of Goods and Services Sold |
| Research and development | 345.90M USD | Research and Development Expense |
| Selling, general and administration | 1.31B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $515.70M | $3.05B | $883.20M | $345.90M | $1.31B | 16.89% |
| 2026-03-31 | $507.10M | $2.90B | $841.00M | $331.20M | $1.22B | 17.48% |
| 2025-12-31 | $473.80M | $2.71B | $768.20M | $301.10M | $1.17B | 17.50% |
| 2025-09-30 | $436.80M | $2.52B | $719.60M | $270.80M | $1.09B | 17.32% |
| 2025-06-30 | $407.30M | $2.36B | $690.20M | $248.50M | $1.01B | 17.26% |
| 2025-03-31 | $340.80M | $2.20B | $651.00M | $229.00M | $978.10M | 15.50% |
| 2024-12-31 | $308.90M | $2.07B | $625.90M | $219.60M | $917.20M | 14.91% |
| 2024-09-30 | $306.00M | $1.98B | $607.90M | $201.00M | $869.00M | 15.42% |
| 2024-06-30 | $272.70M | $1.87B | $580.50M | $203.90M | $815.60M | 14.56% |
| 2024-03-31 | $249.20M | $1.88B | $554.50M | $205.10M | $771.90M | 13.27% |
| 2023-12-31 | $220.00M | $1.70B | $537.20M | $205.00M | $734.90M | 12.96% |
| 2023-09-30 | $137.10M | $1.47B | $541.00M | $212.50M | $666.40M | 9.33% |
| 2023-06-30 | $85.20M | $1.32B | $554.10M | $199.70M | $626.10M | 6.46% |
| 2023-03-31 | $27.40M | $1.07B | $531.60M | $187.20M | $621.80M | 2.56% |
| 2022-12-31 | $37.60M | $1.06B | $499.70M | $180.20M | $587.80M | 3.56% |
| 2022-09-30 | $63.80M | $1.10B | $441.80M | $172.50M | (m) | 5.80% |
| 2022-06-30 | $94.60M | $1.08B | $376.20M | $165.00M | (m) | 8.76% |
| 2022-03-31 | $147.60M | $1.10B | $347.60M | $162.50M | (m) | 13.46% |
| 2021-12-31 | $126.00M | $1.10B | $346.70M | $160.10M | $466.00M | 11.47% |
| 2021-09-30 | $69.00M | $1.04B | $337.20M | $156.60M | (m) | 6.65% |
| 2021-06-30 | $59.10M | $995.60M | $332.50M | $157.90M | (m) | 5.94% |
| 2021-03-31 | $60.30M | $958.70M | $335.80M | $152.00M | (m) | 6.29% |
| 2020-12-31 | $51.50M | $904.40M | $322.10M | $146.80M | $384.00M | 5.69% |
| 2020-09-30 | $76.90M | $867.70M | $312.40M | $141.40M | (m) | 8.86% |
| 2020-06-30 | $70.10M | $825.80M | $299.20M | $133.90M | (m) | 8.49% |
| 2020-03-31 | $50.20M | $776.60M | $276.10M | $132.70M | (m) | 6.46% |
| 2019-12-31 | $50.00M | $738.20M | $257.90M | $129.70M | (m) | 6.77% |
| 2019-09-30 | $48.10M | $693.71M | $237.21M | $122.20M | (m) | 6.93% |
| 2019-06-30 | $37.97M | $652.67M | $217.28M | $113.76M | (m) | 5.82% |
| 2019-03-31 | $34.69M | $599.80M | $198.75M | $100.29M | (m) | 5.78% |
| 2018-12-31 | $27.42M | $563.82M | $193.66M | $88.61M | (m) | 4.86% |
| 2018-09-30 | $10.42M | $529.44M | $190.08M | $78.87M | (m) | 1.97% |
| 2018-06-30 | $5.60M | $500.14M | $189.12M | $77.25M | (m) | 1.12% |
| 2018-03-31 | $-2.08M | $485.63M | $192.05M | $76.86M | (m) | -0.43% |
| 2017-12-31 | $-7.39M | $463.77M | $186.60M | $74.45M | (m) | -1.59% |
| 2017-09-30 | $-10.75M | $436.82M | $178.22M | $71.70M | (m) | -2.46% |
| 2017-06-30 | $-10.38M | $409.92M | $169.30M | $65.30M | (m) | -2.53% |
| 2017-03-31 | $-8.31M | $387.49M | $161.06M | $60.22M | (m) | -2.15% |
| 2016-12-31 | $-10.70M | $366.99M | $155.90M | $55.71M | (m) | -2.92% |
| 2016-09-30 | $-19.18M | $347.21M | $155.07M | $52.57M | (m) | -5.53% |
| 2016-06-30 | $-48.43M | $384.07M | $201.12M | $48.87M | (m) | -12.61% |
| 2016-03-31 | $-61.20M | $357.29M | $194.28M | $47.99M | (m) | -17.13% |
| 2015-12-31 | $-60.77M | $324.23M | $176.07M | $43.21M | (m) | -18.74% |
| 2015-09-30 | $-38.98M | $296.67M | $157.16M | $37.60M | (m) | -13.14% |
| 2015-06-30 | $-26.12M | $284.35M | $142.45M | $34.72M | (m) | -9.19% |
| 2015-03-31 | $-19.04M | $280.77M | $137.49M | $29.33M | (m) | -6.78% |
| 2014-12-31 | $-12.30M | $288.72M | $145.43M | $27.90M | (m) | -4.26% |
| 2014-09-30 | $-9.84M | $284.69M | $145.06M | $27.04M | (m) | -3.45% |
| 2014-06-30 | $-24.27M | $270.81M | $141.82M | $25.65M | (m) | -8.96% |
| 2014-03-31 | $-24.82M | $258.89M | $138.84M | $24.15M | (m) | -9.59% |
| 2013-12-31 | $-29.14M | $247.08M | $134.68M | $21.77M | (m) | -11.79% |
| 2013-09-30 | $-35.43M | $236.38M | $131.68M | $21.19M | (m) | -14.99% |
| 2013-06-30 | $-26.59M | $230.03M | $128.33M | $21.98M | (m) | -11.56% |
| 2013-03-31 | $-31.28M | $220.97M | $123.78M | $23.32M | (m) | -14.16% |
| 2012-12-31 | $-35.97M | $211.37M | $119.03M | $24.36M | (m) | -17.02% |
| 2012-09-30 | $-40.40M | $200.73M | $113.64M | $24.32M | (m) | -20.12% |
| 2012-06-30 | $-41.69M | $190.57M | $109.31M | $22.39M | (m) | -21.88% |
| 2012-03-31 | $-46.09M | $171.75M | $98.28M | $22.71M | (m) | -26.83% |
| 2011-12-31 | $-42.47M | $152.25M | $85.54M | $21.86M | (m) | -27.89% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | $104.42M | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-38.63M | $96.97M | $53.24M | $16.57M | (m) | -39.84% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $-59.36M | $66.03M | $47.73M | $13.23M | (m) | -89.89% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |